Abbott Laboratories (ABT)

Revenue

$13.01B

Quarterly · Period ending: · USD

ABT logo

ABT Revenue

Latest reported$13.01B
ABT Quarterly Revenue ($822.70M → $13.01B)
High-resolution chart · PNG

ABT revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Revenue — Quarterly (USD)
Period endingRevenue (USD)
13,013,000,000
12,593,000,000
11,164,000,000
11,459,000,000
11,369,000,000
11,142,000,000
10,358,000,000
10,974,000,000
10,635,000,000
10,377,000,000
9,964,000,000
10,241,000,000
10,143,000,000
9,978,000,000
9,747,000,000
10,091,000,000
10,410,000,000
11,257,000,000
11,895,000,000
11,468,000,000
10,928,000,000
10,223,000,000
10,456,000,000
10,701,000,000
8,853,000,000
7,328,000,000
7,726,000,000
8,314,000,000
8,076,000,000
7,979,000,000
7,535,000,000
7,765,000,000
7,656,000,000
7,767,000,000
7,390,000,000
7,589,000,000
6,829,000,000
6,637,000,000
6,335,000,000
5,333,000,000
5,302,000,000
5,333,000,000
4,885,000,000
5,188,000,000
5,150,000,000
5,170,000,000
4,897,000,000
5,356,000,000
5,104,000,000
5,551,000,000
5,244,000,000
5,655,000,000
5,369,000,000
5,446,000,000
5,378,000,000
10,836,936,000
9,773,000,000
9,807,000,000
9,457,000,000
10,377,453,000
9,817,000,000
9,616,000,000
9,041,000,000
9,967,848,000
8,675,000,000
8,826,000,000
7,698,000,000
8,790,127,000
7,761,000,000
7,495,000,000
6,718,368,000
7,950,268,000
7,497,660,000
7,314,021,000
6,765,603,000
7,221,351,000
6,376,706,000
6,370,620,000
5,290,284,000
6,217,969,000
5,573,770,000
5,501,124,000
5,183,459,000
6,047,334,000
5,383,995,000
5,523,800,000
5,382,679,000
5,654,443,000
4,681,669,000
4,703,049,000
5,216,053,000
5,530,582,000
4,845,881,000
4,723,635,000
4,580,463,000
4,839,249,000
4,341,236,000
4,314,889,000
4,189,289,000
4,445,062,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.